Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Seres Therapeutics, Inc. < Previous 1 2 3 Next > Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates May 08, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 06, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024 May 06, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT April 09, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 28, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 19, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates March 05, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024 February 28, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference February 27, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz February 26, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 17, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155 January 09, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference January 04, 2024 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023 December 07, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET November 28, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 Million November 02, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST October 30, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Highlight VOWST™ Data at IDWeek October 12, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 06, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 08, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference September 07, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates August 08, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 04, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference August 01, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Host Second Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on August 8, 2023 August 01, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 14, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Named to TIME100 Most Influential Companies List June 21, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics and Nestlé Health Science Present Late-Breaking Data on VOWST™, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection in Adults, at ASM Microbe 2023 June 17, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics to Present at Goldman Sachs Global Healthcare Conference June 09, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 09, 2023 From Seres Therapeutics, Inc. Via Business Wire Tickers MCRB < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.